CN106389777A - 一种治疗糖尿病伴高血脂的中药及制备方法 - Google Patents
一种治疗糖尿病伴高血脂的中药及制备方法 Download PDFInfo
- Publication number
- CN106389777A CN106389777A CN201611072202.2A CN201611072202A CN106389777A CN 106389777 A CN106389777 A CN 106389777A CN 201611072202 A CN201611072202 A CN 201611072202A CN 106389777 A CN106389777 A CN 106389777A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- hyperlipidemia
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 89
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 50
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- 239000009636 Huang Qi Substances 0.000 claims abstract description 16
- 239000008517 radix Trichosanthis Substances 0.000 claims abstract description 15
- 239000000203 mixture Substances 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 241000756943 Codonopsis Species 0.000 claims description 14
- 238000009835 boiling Methods 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 27
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 230000003014 reinforcing effect Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 230000001976 improved effect Effects 0.000 abstract description 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 108010023302 HDL Cholesterol Proteins 0.000 description 6
- 108010028554 LDL Cholesterol Proteins 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 230000002526 effect on cardiovascular system Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 231100001274 therapeutic index Toxicity 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 235000019890 Amylum Nutrition 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 238000002562 urinalysis Methods 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 206010062198 microangiopathy Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗糖尿病伴高血脂的中药及制备方法,所述的中药包括如下重量份数的各组分:黄芪10~20份、佛手3~10份、山药5~12份、川芎4~10份、赤芍3~10份、五味子3~10份,山萸肉6~15份、天花粉6~15份、制何首乌8~18份、党参5~15份,所述中药各组分按照经过浸泡、煎煮制得中药制剂。本发明所述治疗糖尿病伴高血脂的中药,各药相辅相成,标本兼治,扶正祛邪,治疗糖尿病合并高血脂效果显著且无副作用;本发明中药组合物为天然纯中药制剂,不良反应和副作用显著降低,且本发明中药组合物作用全面,药物治疗效果更佳,显著提高了糖尿病患者的用药依从性,提高患者的生活质量。
Description
技术领域
本发明属于中药领域,具体涉及一种治疗糖尿病伴高血脂的中药及制备方法。
背景技术
糖尿病(Diabetes mellitus,DM)是由于体内胰岛素分泌不足或作用缺陷所致的一种以糖、脂肪、蛋白质等代谢紊乱为主要特征的常见内分泌代谢性疾病。近年来,随着人们生活水平的提高、生活方式的改变等诸多因素,全球糖尿病的发病率增长迅速,糖尿病已经成为继肿瘤、心血管病变之后的第三大严重威胁人类健康和生命的常见疾病。糖尿病的临床表现属于中医学的消渴范畴,以多食、多饮、多尿、体重减轻等为常见症状,并且随着病程的延长,病人逐渐感到软弱无力,体重明显减轻,继而出现各系统受损(心血管、脑血管、神经、肾、眼等)的一系列晚期临床表现,即并发糖尿病肾病、糖尿病心血管病变、糖尿病性神经病变等慢性并发症,成为患者死亡的主要原因。
高血脂是中老年常见病、多发病,是严重心脑血管事件,特别是动脉粥样硬化的严重危险因素。糖尿病患者同时伴有高血脂病,其脑卒中及冠心病的发病率远高于其他疾病,也是糖尿病导致动脉硬化,诱发心脑血管疾病及微血管病变以至过早致残、致死的主要原因。两者同时存在,则脂代谢的异常可进一步加重糖代谢紊乱,二则互为因果,严重影响患者的生活质量及预期寿命,也给临床治疗带来严重困难。结合现代中医药发展理论,从提高药物疗效、降低副作用的角度出发,经过对中药成分进行筛选提取或配伍制得的制剂,其副作用小,安全性高,具有化学合成药不能比拟的优势。
发明内容
针对现有技术中的缺陷,本发明的目的是提供一种能够改善和调节血糖、血脂水平,效果好、副作用少的治疗糖尿病伴高血脂的中药及其制备方法。
本发明解决技术问题采用如下技术方案:
本发明涉及一种治疗糖尿病伴高血脂的中药,所述的中药包括如下重量份数的各组分:黄芪10~20份、佛手3~10份、山药5~12份、川芎4~10份、赤芍3~10份、五味子3~10份,山萸肉6~15份、天花粉6~15份、制何首乌8~18份、党参5~15份。
优选地,所述治疗糖尿病伴高血脂的中药,包括如下重量份数的各组分:黄芪15~20份、佛手5~8份、山药6~10份、川芎5~8份、赤芍5~10份、五味子3~10份,山萸肉8~15份、天花粉8~15份、制何首乌10~18份、党参6~15份。
优选地,所述治疗糖尿病伴高血脂的中药,包括如下重量份数的各组分:黄芪20份、佛手6份、山药10份、川芎6份、赤芍8份、五味子6份、山萸肉12份、天花粉10份、制何首乌12份、党参12份。
优选地,所述的治疗糖尿病伴高血脂的中药,包括如下重量份数的各组分:黄芪15份、佛手6份、山药8份、川芎6份、赤芍6份、五味子6份、山萸肉10份、天花粉10份、制何首乌12份、党参10份。
本发明还提供所述治疗糖尿病伴高血脂的中药的制备方法,所述制备方法如下:将各组分按照比例混合均匀,加20~30℃的水浸泡20~30min,放入煎药机,煎煮40min,滤去药渣,将药液按160~200ml/袋压入中药袋,即得,放冰箱0-8℃冷藏保存,早晚各一次,一次一袋,饭后服用。
优选地,所述加入水的总重量为中药总重量的10~12倍。
本发明还提供所述治疗糖尿病伴高血脂的中药的另一种制备方法,所述制备方法如下:各中药组分混合后,加入中药总重量的8~10倍的水浸泡0.5~1h,加热煎煮40~50min,过滤得煎煮液,向药渣中加入中药总重量6~8倍的水二次煎煮,煎煮30~40min,过滤得煎煮液,将两次煎煮液合并浓缩至相对密度为1.20~1.27(50-70℃),加入80~95%的乙醇调节含醇量达到50%,搅匀,静置12h以上,滤过,滤液回收乙醇,浓缩至无醇味的稠膏,减压干燥成干浸膏,在加入药学可接受的成型剂辅料,如可压性淀粉、乳糖、糊精、微晶纤维,硬脂酸镁、羟甲基淀粉钠等,制成中药制剂。
优选地,所述中药制剂包括颗粒剂、胶囊剂、片剂。
本发明所述治疗糖尿病伴高血脂的中药组合物,是发明人基于自己多年临床经验和对糖尿病及高血脂的发病机理的深刻认识,经反复优化验证而得。本发明所述中药的各组分的药理药性如下:
黄芪,味甘、微苦,归肺、脾、肾经,具有补气升阳、益气固表、活血通络,补脾润肺、生津止渴、托毒生肌及利水消肿等诸多功效,黄芪主要含苷类、多糖、氨基酸、微量元素以及黄酮等,能促进机体代谢、抗疲劳、增强机体免疫功能、强心、抗心律失常、抗缺氧、保护心脑血管等多种作用。
佛手,味甘微辛、性温,入肝、胃经,具有理气舒肝、和胃化痰的功效。
山药,味甘,性平,入肺、脾、肾经,具有健脾益胃、促进消化、滋肾益精、益肺止咳、降低血糖的功效,山药富含淀粉酶、多酚氧化酶、皂甙、黏液蛋白、维生素及微量元素,能有效阻止血脂在血管壁的沉淀,预防心血疾病,取得益志安神、延年益寿的功效。
川芎,味辛,性温,入肝、胆经,行气开郁,法风燥湿,活血止痛。
赤芍,味苦,性微寒,归肝经,清热凉血,散瘀止痛。
五味子,味酸、甘,性温,归肺、心、肾经,具有敛肺滋肾、生津敛汗、涩精止泻、宁心安神的功效。
山萸肉,味酸、性微温,入肝、肾经,具有补益肝肾,涩精固脱的功效。
天花粉,味甘、微苦,微寒,归肺、胃经,清热生津,消肿排脓。
何首乌,味苦甘涩,性微寒,入肝、肾经,《 本草求真》指出“首乌入通于肝,为阴中之阳药,故专入肝经以为益血祛风之用,其兼补肾者,亦因补肝而兼及也”,何首乌具有养血滋阴、润肠通便、截疟、祛风解毒之功效。
党参,味甘、性平,归脾、肺经,具有补中益气,和脾胃、生津除烦渴之功效。
以上各中药组分相互配合,标本兼治,扶正祛邪,治疗糖尿病合并高血脂效果显著且无副作用。
与现有技术相比,本发明所述治疗糖尿病伴高血脂的中药,各药相辅相成,标本兼治,扶正祛邪,治疗糖尿病合并高血脂效果显著且无副作用;本发明中药组合物为天然纯中药制剂,不良反应和副作用显著降低,且本发明中药组合物作用全面,药物治疗效果更佳,显著提高了糖尿病患者的用药依从性,并提高了患者的生活质量。
具体实施方式
下面结合具体实施例,进一步阐述本发明。这些实施例仅用于说明本发明而不用于限制本发明的范围。
实施例1:
本实施例涉及一种治疗糖尿病伴高血脂的中药及制备方法;
所述治疗糖尿病伴高血脂的中药包括如下重量份数的各组分:黄芪15份、佛手6份、山药8份、川芎6份、赤芍6份、五味子6份、山萸肉10份、天花粉10份、制何首乌12份、党参10份。
所述中药制备方法如下:将各组分按照比例混合均匀,加20℃的中药总重量12倍的水浸泡30min,放入煎药机,煎煮40min,滤去药渣,将药液按180ml/袋压入中药袋,即得,放冰箱0-8℃冷藏保存。
实施例2:
本实施例涉及一种治疗糖尿病伴高血脂的中药及制备方法;
所述治疗糖尿病伴高血脂的中药包括如下重量份数的各组分:黄芪20份、佛手8份、山药10份、川芎5份、赤芍8份、五味子6份、山萸肉12份、天花粉10份、制何首乌12份、党参12份。
所述中药制备方法如下:将各组分按照比例混合均匀,加30℃的中药总重量10倍的水浸泡20min,放入煎药机,煎煮40min,滤去药渣,将药液按160ml/袋压入中药袋,即得,放冰箱0-8℃冷藏保存。
实施例3:
本实施例涉及一种治疗糖尿病伴高血脂的中药及制备方法;
所述治疗糖尿病伴高血脂的中药包括如下重量份数的各组分:黄芪10份、佛手10份、山药5份、川芎10份、赤芍5份、五味子3份,山萸肉6份、天花粉15份、制何首乌8份、党参5份。
所述中药制备方法如下:将各组分按照比例混合均匀,加30℃的中药总重量10倍的水浸泡20min,放入煎药机,煎煮40min,滤去药渣,将药液按200ml/袋压入中药袋,即得,放冰箱0-8℃冷藏保存。
实施例4:
本实施例涉及一种治疗糖尿病伴高血脂的中药及制备方法;
所述治疗糖尿病伴高血脂的中药包括如下重量份数的各组分:黄芪20份、佛手3份、山药12份、川芎4份、赤芍10份、五味子10份,山萸肉15份、天花粉6份、制何首乌18份、党参6份。
所述中药制备方法如下:各中药组分混合后,加入中药总重量的8倍的水浸泡1h,加热煎煮40min,过滤得煎煮液,向药渣中加入初始中药总重量8倍的水二次煎煮,煎煮40min,过滤得煎煮液,将两次煎煮液合并浓缩至相对密度为1.20(50℃),加入95%的乙醇调节含醇量达到50%,搅匀,静置12h以上,滤过,滤液回收乙醇,浓缩至无醇味的稠膏,减压干燥成干浸膏,加入乳糖和糊精,湿法制粒,得颗粒剂。
实施例5:
本实施例涉及一种治疗糖尿病伴高血脂的中药及制备方法;
所述治疗糖尿病伴高血脂的中药包括如下重量份数的各组分:黄芪15份、佛手5、山药6份、川芎8份、赤芍3份、五味子7份,山萸肉8份、天花粉8份、制何首乌10份、党参15份。
所述中药制备步骤如下:所述中药制备步骤如下:各中药组分混合后,加入中药总重量的10倍的水浸泡0.5,加热煎煮50min,过滤得煎煮液,向药渣中加入初始中药总重量6倍的水二次煎煮,煎煮30min,过滤得煎煮液,将两次煎煮液合并浓缩至相对密度为1.27(60℃),加入80%的乙醇调节含醇量达到50%,搅匀,静置12h以上,滤过,滤液回收乙醇,浓缩至无醇味的稠膏,减压干燥成干浸膏,加入可压性淀粉和硬脂酸镁,造粒、压片,制得片剂。
临床资料:
一般资料:糖尿病合并高血脂的患者56例,其中,男33例,女23例;年龄45岁-68岁;病程2-8年,随机将患者分为对照组和治疗组,每组28例,两组患者性别、年龄、病程等方面比较均未见显著性差异。患者均符合WHO1999年糖尿病诊断和分类标准中2型糖尿病的诊断标准,同时符合高脂血症的诊断标准:三酰甘油(TG)≥1.7 mmol/L或者总胆固醇(TC)≥5.7mmol/L。
服药方法:对照组患者维持原糖尿病的治疗方案,治疗组在原糖尿病的治疗方案基础上加服本发明实施例1中制得的汤剂,每日2次,早晚各一次,饭后服用,1个月为1个疗程,观察3个疗程。
疗效判定标准
显效:TC下降 ≥ 20%,TG下降 ≥ 40%,HDL-C上升≥ 0.26 mmol/L;LDL-C下降≥ 20%,达以上任何一项即可;
有效:TC下降 10%-20%,TG下降 20%- 40%,HDL-C上升0.104- 0.26mmol/L;LDL-C下降10- 20%,达其中任何一项即可。
无效:治疗后未达有效标准者。
治疗结果统计:
由上表可以看出,本发明所述治疗糖尿病伴高血脂的中药,治疗效果好,见效快,无副作用。
典型病例及疗效:
夏某,女,46岁,2型糖尿病伴高脂血症4年,眩晕头痛、憋闷、气短、乏力、少言少动、口干喜饮、失眠多梦,常年控制饮食,采用本发明实施例1中的中药汤剂治疗前,空腹血糖8.2mmol/L,TC 8.25 mmol/L,HDL-C 0.75 mmol/L,LDL-C 5.0 mmol/L,TG 2.36 mmol/L,体治疗指数BMI:27.7,3个疗程后,症状基本消失,空腹血糖6.6 mmol/L,TC 5.98 mmol/L,HDL-C1.10 mmol/L,LDL-C 3.62 mmol/L,TG 1.68 mmol/L,体治疗指数BMI:23.1,疗效显著,患者于治疗前后分别进行了血常规、尿常规、大便常规、肝肾功能检测,未发现明显异常的改变。
候某,男,68岁,2型糖尿病伴高脂血症3年,眩晕头痛、腰膝酸软、气短、乏力、胸闷刺痛、心悸不安、夜尿频数,常年控制饮食,采用本发明实施例1中的中药汤剂治疗前,空腹血糖8.9mmol/L,TC 8.77 mmol/L,HDL-C 0.7mmol/L,LDL-C 4.9 mmol/L,TG 2.64mmol/L,体治疗指数BMI:32.3,3个疗程后,症状基本消失,空腹血糖6.7 mmol/L,TC 6.20 mmol/L,HDL-C 1.01 mmol/L,LDL-C 3.57mmol/L,TG 1.65 mmol/L,体治疗指数BMI:28.2,疗效显著,患者于治疗前后分别进行了血常规、尿常规、大便常规、肝肾功能检测,未发现明显异常的改变。
以上对本发明的具体实施例进行了描述。需要理解的是,本发明并不局限于上述特定实施方式,本领域技术人员可以在权利要求的范围内做出各种变形或修改,这并不影响本发明的实质内容。
Claims (8)
1.一种治疗糖尿病伴高血脂的中药,其特征在于:所述的中药包括如下重量份数的各组分:黄芪10~20份、佛手3~10份、山药5~12份、川芎4~10份、赤芍3~10份、五味子3~10份,山萸肉6~15份、天花粉6~15份、制何首乌8~18份、党参5~15份。
2.根据权利要求1所述的治疗糖尿病伴高血脂的中药,其特征在于:所述的中药包括如下重量份数的各组分:黄芪15~20份、佛手5~8份、山药6~10份、川芎5~8份、赤芍5~10份、五味子3~10份,山萸肉8~15份、天花粉8~15份、制何首乌10~18份、党参6~15份。
3.根据权利要求2所述的治疗糖尿病伴高血脂的中药,其特征在于:所述的中药包括如下重量份数的各组分:黄芪20份、佛手8份、山药10份、川芎5份、赤芍8份、五味子6份、山萸肉12份、天花粉10份、制何首乌12份、党参12份。
4.根据权利要求2所述的治疗糖尿病伴高血脂的中药,其特征在于:所述的中药包括如下重量份数的各组分:黄芪15份、佛手6份、山药8份、川芎6份、赤芍6份、五味子6份、山萸肉10份、天花粉10份、制何首乌12份、党参10份。
5.一种如权利要求1-4中任一项所述治疗糖尿病伴高血脂的中药的制备方法,其特征在于:所述制备方法如下:将各组分按照比例混合均匀,加20~30℃的水浸泡20~30min,放入煎药机,煎煮40min,滤去药渣,将药液按160~200ml/袋压入中药袋,即得。
6.根据权利要求5所述治疗糖尿病伴高血脂的中药的制备方法,其特征在于:所述加入水的总重量为中药总重量的10~12倍。
7.一种如权利要求1-4中任一项所述治疗糖尿病伴高血脂的中药的制备方法,其特征在于:所述制备方法如下:各中药组分混合后,加入中药总重量8~10倍的水浸泡0.5~1h,加热煎煮40~50min,过滤得煎煮液,向药渣中加入初始中药总重量6~8倍的水二次煎煮,煎煮30~40min,过滤得煎煮液,将两次煎煮液合并浓缩至相对密度为1.20~1.27(50-70℃),加入80~95%的乙醇调节含醇量达到50%,搅匀,静置12h以上,滤过,滤液回收乙醇,浓缩至无醇味的稠膏,减压干燥成干浸膏,加入药学可接受的成型剂辅料,制成中药制剂。
8.根据权利要求7所述治疗糖尿病伴高血脂的中药的制备方法,其特征在于:所述中药制剂包括颗粒剂、胶囊剂、片剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611072202.2A CN106389777A (zh) | 2016-11-29 | 2016-11-29 | 一种治疗糖尿病伴高血脂的中药及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611072202.2A CN106389777A (zh) | 2016-11-29 | 2016-11-29 | 一种治疗糖尿病伴高血脂的中药及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106389777A true CN106389777A (zh) | 2017-02-15 |
Family
ID=58084592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611072202.2A Pending CN106389777A (zh) | 2016-11-29 | 2016-11-29 | 一种治疗糖尿病伴高血脂的中药及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106389777A (zh) |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1443544A (zh) * | 2002-03-07 | 2003-09-24 | 张世均 | 一种治疗糖尿病及防治并发症的中药降糖通脉灵及制备方法 |
CN1745835A (zh) * | 2004-09-07 | 2006-03-15 | 朱智文 | 糖尿病丸及其配方 |
CN101491627A (zh) * | 2008-11-27 | 2009-07-29 | 北京宏泰康达医药科技有限公司 | 一种治疗ⅱ型糖尿病和高血脂的中药组合物 |
CN102166297A (zh) * | 2010-02-26 | 2011-08-31 | 田向阳 | 一种治疗糖尿病的中药配方 |
CN102274429A (zh) * | 2011-07-28 | 2011-12-14 | 连建亭 | 一种治疗糖尿病的中药组合物 |
CN102274471A (zh) * | 2011-09-16 | 2011-12-14 | 姜元寿 | 一种治疗糖尿病的药物组合物 |
CN102600438A (zh) * | 2012-04-21 | 2012-07-25 | 韩合旭 | 治疗糖尿病、高血压、高血脂和冠心病的药物 |
CN102949598A (zh) * | 2012-12-04 | 2013-03-06 | 曹法政 | 一种缓解糖尿病症状的丸剂及制备方法 |
CN103446385A (zh) * | 2013-08-26 | 2013-12-18 | 山西康禾农业有限责任公司 | 一种治疗糖尿病并发症的中药制剂 |
CN103494995A (zh) * | 2013-09-29 | 2014-01-08 | 南阳市食用菌技术交流中心(普通合伙) | 治疗高血压高血糖高血脂的组合药物 |
CN104352942A (zh) * | 2014-11-26 | 2015-02-18 | 杨其义 | 一种治疗糖尿病的中药组合物 |
CN104491621A (zh) * | 2014-12-10 | 2015-04-08 | 高田田 | 一种治疗糖尿病的中药组合物 |
-
2016
- 2016-11-29 CN CN201611072202.2A patent/CN106389777A/zh active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1443544A (zh) * | 2002-03-07 | 2003-09-24 | 张世均 | 一种治疗糖尿病及防治并发症的中药降糖通脉灵及制备方法 |
CN1745835A (zh) * | 2004-09-07 | 2006-03-15 | 朱智文 | 糖尿病丸及其配方 |
CN101491627A (zh) * | 2008-11-27 | 2009-07-29 | 北京宏泰康达医药科技有限公司 | 一种治疗ⅱ型糖尿病和高血脂的中药组合物 |
CN102166297A (zh) * | 2010-02-26 | 2011-08-31 | 田向阳 | 一种治疗糖尿病的中药配方 |
CN102274429A (zh) * | 2011-07-28 | 2011-12-14 | 连建亭 | 一种治疗糖尿病的中药组合物 |
CN102274471A (zh) * | 2011-09-16 | 2011-12-14 | 姜元寿 | 一种治疗糖尿病的药物组合物 |
CN102600438A (zh) * | 2012-04-21 | 2012-07-25 | 韩合旭 | 治疗糖尿病、高血压、高血脂和冠心病的药物 |
CN102949598A (zh) * | 2012-12-04 | 2013-03-06 | 曹法政 | 一种缓解糖尿病症状的丸剂及制备方法 |
CN103446385A (zh) * | 2013-08-26 | 2013-12-18 | 山西康禾农业有限责任公司 | 一种治疗糖尿病并发症的中药制剂 |
CN103494995A (zh) * | 2013-09-29 | 2014-01-08 | 南阳市食用菌技术交流中心(普通合伙) | 治疗高血压高血糖高血脂的组合药物 |
CN104352942A (zh) * | 2014-11-26 | 2015-02-18 | 杨其义 | 一种治疗糖尿病的中药组合物 |
CN104491621A (zh) * | 2014-12-10 | 2015-04-08 | 高田田 | 一种治疗糖尿病的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107789484B (zh) | 一种治疗月经不调的中药组合物及其制备方法 | |
CN104189472A (zh) | 一种治疗原发性低血压病的中药组合物 | |
CN115779064A (zh) | 一种黄芪扶正方及其制剂与应用 | |
CN103977265A (zh) | 一种铁皮石斛复方制剂及其制备方法 | |
CN106389777A (zh) | 一种治疗糖尿病伴高血脂的中药及制备方法 | |
CN106173705A (zh) | 一种益精补肾养心安神饮料及制备加工方法 | |
CN104857370A (zh) | 一种治疗乳腺癌症的中药组合物 | |
CN105168563A (zh) | 一种治疗白发脱发的保健饮品 | |
CN104127670A (zh) | 一种治疗心律不齐的中药汤剂 | |
CN104116908A (zh) | 一种治疗心律不齐的中药汤剂 | |
CN103933219A (zh) | 一种治疗高血脂的中药配方 | |
CN103041361B (zh) | 一种治疗三高症的药物及其制备方法 | |
CN106620001A (zh) | 一种治疗糖尿病足的中药及制备方法 | |
CN103479868B (zh) | 一种治疗心虚胆怯型心律失常的中药及制备方法 | |
CN108853340A (zh) | 一种滋养肝肾的中药及其制备方法 | |
CN106309738A (zh) | 一种治疗糖尿病肾病的中药及制备方法 | |
CN106421530A (zh) | 一种治疗糖尿病的中药及制备方法 | |
CN105381099A (zh) | 一种用于治疗低血糖的药物及制备方法 | |
CN102335359A (zh) | 一种治疗心律失常的中药 | |
CN105878732A (zh) | 一种治疗糖尿病的中药及其制备方法 | |
CN116076639A (zh) | 一种抗疲劳提高免疫力的保健饮品及其制备工艺 | |
CN105327120A (zh) | 一种用于治疗风湿性多肌痛的中药丸剂及制备方法 | |
CN113616749A (zh) | 一种治疗三高的中药组合物及其制备方法 | |
CN115154546A (zh) | 一种中药组合物及其制备方法 | |
CN110292603A (zh) | 一种治疗糖尿病的回药复方及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170215 |
|
RJ01 | Rejection of invention patent application after publication |